ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 21 filers reported holding ARCTURUS THERAPEUTICS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $416,000 | – | 60,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diametric Capital, LP | 55,186 | $377,000 | 0.30% |
| ARK Investment Management | 927,144 | $6,332,000 | 0.18% |
| DAFNA Capital Management LLC | 47,255 | $323,000 | 0.14% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 47,714 | $326,000 | 0.02% |
| Nikko Asset Management Americas, Inc. | 64,099 | $438,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,789 | $169,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 106,436 | $727,000 | 0.01% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 27,300 | $186,000 | 0.00% |
| Creative Planning | 60,971 | $416,000 | 0.00% |
| CITIGROUP INC | 171 | $1,000 | 0.00% |